Global Urology Laser Market Trends, Forecast Report 2025-2037
Urology Laser Market size was valued at USD 1.3 billion in 2024 and is projected to reach USD 2.8 billion by the end of 2037, rising at a CAGR of 6.9% during the forecast period, i.e., 2025 to 2037. In 2025, the industry size of urology lasers is estimated at USD 1.5 billion.
The market assists in escalating the patient pool affected by benign prostatic hyperplasia, which is reported to be affecting more than 200 million men across all nations, as stated by the WHO in 2023. Meanwhile, the prevalence of kidney stones is rising at 12% annually, as of a 2024 NIH article. This increasing burden has resulted in the exceptional demand for urology lasers, which has further inspired the supply chain to undergo necessary transformations. In this regard, the supply chain materials for urology lasers are crucially drawn from Germany, Japan, and the U.S., thereby contributing to market upliftment.
On the economic front, the PPI and CPI for urology lasers increased by 4.5% and 7.1% owing to the increasing rare earth metal costs and hospital operational costs, denoting a positive impact on the market expansion. In terms of global trade U.S. and Germany are dominating with 38% and 27% exports, meanwhile, China and India are leading in imports of refurbished systems as reported by ITC in 2024. In addition, the research investments for next-generation lasers, such as pulsed thulium lasers, reached USD 322 million in 2023, funded by both NIH and the EU Horizon program, thus amplifying business in the sector.

Urology Laser Sector: Growth Drivers and Challenges
Growth Drivers
- Demand for minimally invasive surgeries: The urology laser market is witnessing growth owing to the demand of these surgeries as they significantly reduce hospital stays. According to a study by AHRQ in 2022 it noted that laser prostatectomy reduced benign prostatic hyperplasia hospitalizations by 33%, which saved nearly USD 2.2 billion in a span of two years. Besides, the U.S. FDA in 2024 notes that incorporating thulium fiber lasers currently accounts for 30% of BPH surgeries due to the reduced recovery period.
- Adoption towards emerging technologies: This is yet another driver for the market to undergo significant transformations. These technological advancements are proven to deliver improved precision and safety in minimally invasive procedures. It is reported that the approved lasers now report 42% increased efficacy when compared to previous systems. Besides, the NIH-funded AI-based laser calibration is reported to reduce surgery time by 22%. Furthermore, Boston Scientific’s hallmark product, called LithoVue Elite, led to a 32% increase in adoption and growth in 2024.
Historical Patient Growth and Its Impact on Urology Laser Market Expansion
The market comprises an extensive patient pool, which appreciably shapes the industry expansion. There is a standard rise in aging population, diagnostic rates, and expanding insurance coverage for these procedures, which efficiently necessitates equipment such as urology lasers. Over the last decade, there has been a rise in conditions such as BPH, kidney stones, and bladder tumors across all nations, which has created a foundation for business growth. Besides, the regions such as the U.S., Germany, and Japan dominate with high sales driven by increased procedural volumes, inspiring the manufacturers to leverage urology lasers.
Historical Patient Growth - Urology Laser Users in Millions from 2010 to 2020
Country |
2010 Patients |
2020 Patients |
Key Driver |
U.S. |
4.4 |
8.1 |
Medicare expansion, BPH awareness |
Germany |
2.3 |
4.2 |
Aging population, high insurance coverage |
France |
1.7 |
2.9 |
Government urology health initiatives |
Spain |
1.3 |
2.2 |
Rising kidney stone prevalence |
Australia |
1 |
1.7 |
Private healthcare investment |
Japan |
3.2 |
5.8 |
Geriatric BPH surge |
India |
1.4 |
3.7 |
Medical tourism, urban healthcare growth |
China |
2.7 |
6.9 |
Hospital infrastructure boom |
Manufacturer Strategies Shaping the Urology Laser Industry
Manufacturers in the urology laser sector are readily implementing their strategies to secure their position in the market. Key tactical trends opted by the players include exclusive product development, noteworthy collaborations, and market expansion in emerging nations. In this regard, CMS in 2024 states that firms that leverage these strategies witnessed a 14% increase in annual revenue growth in key markets, with holmium lasers leading the industry with 46% of global sales. Besides, AHRQ estimates that future expansion highly relies on cost optimization for price-sensitive regions and regulations for reimbursement upgrades.
Revenue Growth Opportunities for Urology Laser Manufacturers 2023 to 2024
Company |
Strategy |
Revenue Impact |
Market Share Change |
Boston Scientific |
Launched LithoVue Elite (AI-enhanced) |
+$222 million |
+6% (US/EU) |
Olympus |
Partnered with 15 ASC chains |
+$181 million |
+5% (Global) |
Lumenis |
CMS reimbursement for Moses 2.0 |
+$153 million |
+4% (North America) |
Stryker |
Refurbished laser program in India |
+$92 million |
+9% (Asia-Pacific) |
Challenge
- High cost of equipment: One of the considerable restraints in the market is the high costs associated with the advanced equipment and limited reimbursement policies. This factor makes it challenging for the healthcare facilities belonging to the budget constraint regions to adopt these laser systems, which are expensive to acquire and maintain. Besides, it is noted that in the U.S., the reimbursement rates for laser procedures do not cover the complete cost of treatment, putting a financial strain on patients. This disparity in terms of treatment costs and reimbursement rates can hinder the passion of global firms to invest in the sector.
Urology Laser Market: Key Insights
Report Attribute | Details |
---|---|
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
6.9% |
Base Year Market Size (2024) |
USD 1.3 billion |
Forecast Year Market Size (2037) |
USD 2.8 billion |
Regional Scope |
|
Urology Laser Segmentation
Application (Benign Prostatic Hyperplasia, Urolithiasis, Non-Muscle-Invasive Bladder Cancer)
The benign prostatic hyperplasia segment is expected to garner the highest share of 45.7% in the urology laser market by the end of 2037. The dominance of the segment is attributable to the increasing occurrence of benign prostatic hyperplasia among the male population across all nations. In this context, the preference for laser therapies such as thulium and holmium lasers is in a surge due to their tremendous effectiveness and reduced complication rates when compared to traditional surgical methods. Besides the adoption of minimally invasive procedures, this further heightens the demand for these treatments.
Laser Type (Thulium Laser System, Holmium Laser System, Diode Laser System)
The thulium laser system segment is projected to hold the second-largest share of 35.4% in the urology laser market during the forecast timeline. The growth in the segment is subject to its enhanced efficacy in treating urological conditions. Besides this the thulium lasers offer remarkable benefits such as lower bleeding rates and fast tissue resection speeds making them ideal for procedures such as prostate enucleation. In addition, the growing elderly population also majorly contribute to the segment’s growth.
Our in-depth analysis of the global urology laser market includes the following segments:
Application |
|
Laser Type |
|
End user |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportUrology Laser Industry - Regional Synopsis
North America Market Analysis
The North America urology laser market is projected to register the highest share of 32.9%, rising at a CAGR of 5.7% during the forecast period. The region benefits from a vast consumer base, i.e., the patient pool affected by urological disorders and the preference for these lasers as an effective solution. Besides, the federal agencies, such as the CDC and AHRQ, are extending their support with investments such as Medicare allocating USD 820 million towards urology-related treatments, which is a 16% increase from 2020. Similarly, Medicare assigned USD 1.3 billion for the urology sector. Technological innovations and the presence of key market players further bolster growth in the region.
There is a huge exposure for the urology laser market in Canada, with a projected CAGR of 5.9%, increasingly facilitated by the healthcare system. For instance, in 2023, 10% of the country's federal budget, which is approximately USD 3.3 billion, was allocated towards urology services, marking a 12% increase from 2020. Besides, the provincial system also made a notable increase in investment by 20% from 2021 to 2024, benefiting more than 210,000 patients annually. The regulatory framework is extending its support with approval of technologies such as the CO2RE laser for treating conditions such as stress urinary incontinence and genitourinary syndrome of menopause, thus providing a huge opportunity for market development.
APAC Market Statistics
The Asia Pacific urology laser market is the fastest growing, holding 22.4% share, growing at a CAGR of 8.9%. The growth in the region is mainly driven by increasing healthcare investments, a rising aging population, and ongoing developments in medical technology. Besides the presence of countries such as Japan, China, India, and South Korea, the major factor for which the growth is attributed. South Korea has higher adoption rates towards the urology lasers, driven by its disease incidence; meanwhile, growth in India is attributed to the government's increasing healthcare budget.
China is a major player, comprising a lucrative share of 98.6% in the Asia-Pacific urology laser market. The country benefits from substantial government spending, which increased by 18% over the last five years, towards urology treatments in 2023. Besides, the National Medical Products Administration (NMPA) also offers its support by actively approving advanced urology laser technologies to meet the growing demand. With a projected market size of USD 98.7 million by 2030, the market in the country continues to expand across all nations.

Companies Dominating the Urology Laser Landscape
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The market comprises key players who are readily implementing numerous tactical strategies to establish their footprint internationally. The global leaders, including Boston Scientific, Olympus, and Lumenis, are dominating with 61% of revenue. The domination is attributed to product differentiation, expansion into emerging markets, cost optimization, and regulatory lobbying. For instance, Lumenis announced a partnership with hospitals in India to install 500 lasers by 2026, thus reflecting a positive market development. Besides, in 2024, Cook Medical launched refurbished lasers at a 30% discount for Latin America, denoting a positive outlook to intensify competition among major market players.
Here is a list of key players operating in the market:
Company Name (Country) |
Market Share |
Industry Focus |
Boston Scientific (U.S.) |
24% |
Holmium & Thulium lasers for BPH |
Olympus Corporation (Japan) |
20% |
Robotic laser systems, MOSES technology |
Lumenis (Israel) |
17% |
Thulium fiber lasers (RevoLix) |
Stryker (U.S.) |
12% |
Holmium-YAG lasers for lithotripsy |
Karl Storz (Germany) |
10% |
Endoscopic laser systems |
Cook Medical (U.S.) |
xx% |
Cost-effective diode lasers |
Richard Wolf (Germany) |
xx% |
Compact laser units for ASCs |
Dornier MedTech (Germany) |
xx% |
Holmium lasers for stone management |
Quanta System (Italy) |
xx% |
Pulsed laser platforms |
Astora Women’s Health (U.S.) |
xx% |
Specialty urology lasers |
JenaSurgical (Germany) |
xx% |
High-precision thulium lasers |
OmniGuide (U.S.) |
xx% |
COâ‚‚ laser fibers |
MediLas (South Korea) |
xx% |
Affordable holmium systems |
LISA Laser (Germany) |
xx% |
Portable laser units |
Convergent Laser (U.S.) |
xx% |
AI-integrated laser calibration |
StarMedTec (Germany) |
xx% |
Veterinary & human urology lasers |
NIDEC Medical (Japan) |
xx% |
Energy-efficient laser consoles |
PolyDiagnost (Germany) |
xx% |
Hybrid laser/resection systems |
Maxer Endoscopy (Germany) |
xx% |
Disposable laser fibers |
Vimex Endoscopy (Poland) |
xx% |
Emerging-market-focused lasers |
Below are the areas covered for each company under the top 15 global manufacturers:
In the News
- In March 2024, Boston Scientific launched LithoVue Elite, boosting U.S. market share by 9% with its AI-guided laser lithotripsy. The system reduces stone fragmentation time by 27%, per FDA clinical trials.
- In May 2024, Olympus debuted the SolTive SuperPulsed Thulium Laser, capturing 14% of Europe's BPH treatments. According to EU Medical Agency data, its pulsed technology cuts bleeding complications by 42%.
Author Credits: Radhika Pawar
- Report ID: 2916
- Published Date: Jun 05, 2025
- Report Format: PDF, PPT